Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation

Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation

Although tyrosine Kinase Inhibitors (TKI) has revolutionized the treatment of chronic myeloid leukemia (CML), patients are not cured with the current therapy modalities. Also, the more recent goal of CML treatment is to induce successful treatment-free remission (TFR) among patients achieving durabl...

Full description

Bibliographic Details
Main Authors: Hui Mu, Xiaojian Zhu, Hui Jia, Lu Zhou, Hong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
chronic myeloid leukemia
tyrosine-kinase inhibitor
drug therapy
immunotherapy
treatment-free remission
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.643382/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.643382/full

Similar Items